RAC 3.61% $1.47 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-31

  1. 19,438 Posts.
    lightbulb Created with Sketch. 6528
    The plan for bisantrene before my involvement was to just sell the original formulation as a salvage drug for AML alone with protection coming via orphan drug designation. To the best of my knowledge there was no plan to reformulate bisantrene until after I became CSO.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.47
Change
-0.055(3.61%)
Mkt cap ! $250.5M
Open High Low Value Volume
$1.53 $1.58 $1.46 $143.9K 96.36K

Buyers (Bids)

No. Vol. Price($)
1 230 $1.47
 

Sellers (Offers)

Price($) Vol. No.
$1.48 550 1
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.